Compare · IH vs RCM
IH vs RCM
Side-by-side comparison of iHuman Inc. (IH) and R1 RCM Inc. (RCM): market cap, price performance, sector, and recent activity on the wire.
Summary
- IH operates in Real Estate, while RCM operates in Consumer Discretionary - the two are in different parts of the market.
- RCM is the larger of the two at $6.21B, about 75.0x IH ($82.8M).
- IH has hit the wire 2 times in the past 4 weeks while RCM has been quiet.
- RCM has more recent analyst coverage (25 ratings vs 1 for IH).
- Company
- iHuman Inc.
- R1 RCM Inc.
- Price
- $1.66-3.49%
- $14.32+0.07%
- Market cap
- $82.8M
- $6.21B
- 1M return
- -5.68%
- -
- 1Y return
- -29.36%
- -
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 2
- 0
- Recent ratings
- 1
- 25
iHuman Inc.
iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China.
R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
Latest IH
- SEC Form 6-K filed by iHuman Inc.
- iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
- iHuman Inc. Files 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by iHuman Inc.
- SEC Form 6-K filed by iHuman Inc.
- iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
- SEC Form 3 filed by new insider Lu Wenbin
- SEC Form 3 filed by new insider Dai Peng
- SEC Form 3 filed by new insider Chi Hanfeng
- SEC Form 3 filed by new insider Hayes Wendy W.
Latest RCM
- Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.
- Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)
- Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director Ashdown Clay
- SEC Form 4 filed by Director Wexler Erik G.
- SEC Form 4 filed by Director Nakis Dominic
- Director Bundy Scanlan Agnes returned $472,100 worth of shares to the company (33,014 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Flanagan Joseph Gerard was granted 98,238 shares and returned $49,840,920 worth of shares to the company (3,485,379 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- President Sparby John M. was granted 332,323 shares and returned $9,154,731 worth of shares to the company (640,191 units at $14.30), closing all direct ownership in the company (SEC Form 4)